 | Up a level |
Kluemper, Niklas, Ralser, Damian J., Zarbl, Romina, Schlack, Katrin, Schrader, Andres Jan, Rehlinghaus, Marc, Hoffmann, Michele J., Niegisch, Guenter, Uhlig, Annemarie, Trojan, Lutz, Steinestel, Julie, Steinestel, Konrad, Wirtz, Ralph M., Sikic, Danijel, Eckstein, Markus, Kristiansen, Glen, Toma, Marieta, Hoelzel, Michael, Ritter, Manuel, Strieth, Sebastian, Ellinger, Joerg and Dietrich, Dimo (2021). CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J. Immunother. Cancer, 9 (8). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Uhlig, Johannes, Uhlig, Annemarie, Bachanek, Sophie, Onur, Mehmet Ruhi, Kinner, Sonja, Geisel, Dominik, Kohler, Michael, Preibsch, Heike, Puesken, Michael, Schramm, Dominik, May, Matthias, De Visschere, Pieter, Weber, Marc-Andre and Surov, Alexey (2022). Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors. Eur. Radiol., 32 (2). S. 981 - 990. NEW YORK: SPRINGER. ISSN 1432-1084